Nasdaq
ICCC
ImmuCell Corporation
- Health Care
- Listed 1987
- 1 day
- +2.5%
- 1 month
- +6.6%
- 1 year
- +78.3%
$11.02 · Mkt cap $99.7M
At the 6 Aug 2026 close
Nasdaq
ImmuCell Corporation
$11.02 · Mkt cap $99.7M
At the 6 Aug 2026 close
ImmuCell Corporation trades under the ticker ICCC on Nasdaq, in the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances). It has been listed since 1987. Its market capitalisation is $99.7M. The last closing price was $11.02, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +78.3%, and +6.6% over the past month. Returns are price returns and exclude dividends.
This page exists because ICCC is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.